NAFDAC alerts market to falsified products imitating Forxiga
Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has warned that suspected falsified products imitating Forxiga (dapagliflozin)
Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has warned that suspected falsified products imitating Forxiga (dapagliflozin)
Post-marketing surveillance found out-of-specification results in the hypertension medicine; the Class II recall covers four batches of 28-tablet packs, two of which remain in date.
The order covers YENISOM Healthcare’s entire range rather than named batches, and the agency says the ground is procedural: required entry testing was not carried out.